Position in ERNA
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$1
-$8 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Common Shares in ERNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MONTAG A & ASSOCIATES INC holds $1,116,311 across 17 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
852 | $423,213 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
750 | $213,727 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
5,013 | $195,557 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
194 | $104,168 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
137 | $85,424 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
542 | $47,126 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
80 | $19,277 | |
| 8 | NKTR |
Nektar Therapeutics
|
250 | $17,452 |
All Filings in ERNA
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1 | 8 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $9 | 8 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $8 | 8 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $14 | 8 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $25 | 141 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $61 | 212 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $222 | 212 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $387 | 212 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $338 | 141 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $126 | 70 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $152 | 70 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $158 | 70 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $238 | 70 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $225 | 70 | Shares | Sole | 2023-02-02 | |
| No filing history on record for this holder in this stock. | ||||||